223 related articles for article (PubMed ID: 24098638)
1. Telomere reprogramming and maintenance in porcine iPS cells.
Ji G; Ruan W; Liu K; Wang F; Sakellariou D; Chen J; Yang Y; Okuka M; Han J; Liu Z; Lai L; Gagos S; Xiao L; Deng H; Li N; Liu L
PLoS One; 2013; 8(9):e74202. PubMed ID: 24098638
[TBL] [Abstract][Full Text] [Related]
2. Molecular insights into the heterogeneity of telomere reprogramming in induced pluripotent stem cells.
Wang F; Yin Y; Ye X; Liu K; Zhu H; Wang L; Chiourea M; Okuka M; Ji G; Dan J; Zuo B; Li M; Zhang Q; Liu N; Chen L; Pan X; Gagos S; Keefe DL; Liu L
Cell Res; 2012 Apr; 22(4):757-68. PubMed ID: 22184006
[TBL] [Abstract][Full Text] [Related]
3. Telomerase reverse transcriptase has an extratelomeric function in somatic cell reprogramming.
Kinoshita T; Nagamatsu G; Saito S; Takubo K; Horimoto K; Suda T
J Biol Chem; 2014 May; 289(22):15776-87. PubMed ID: 24733392
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous reversal of the developmental aging of normal human cells following transcriptional reprogramming.
Vaziri H; Chapman KB; Guigova A; Teichroeb J; Lacher MD; Sternberg H; Singec I; Briggs L; Wheeler J; Sampathkumar J; Gonzalez R; Larocca D; Murai J; Snyder E; Andrews WH; Funk WD; West MD
Regen Med; 2010 May; 5(3):345-63. PubMed ID: 20230312
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of Telomere Rejuvenation during Chemical Induction to Pluripotent Stem Cells.
Fu H; Tian CL; Ye X; Sheng X; Wang H; Liu Y; Liu L
Stem Cell Reports; 2018 Jul; 11(1):70-87. PubMed ID: 29861168
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic opportunities: telomere maintenance in inducible pluripotent stem cells.
Gourronc FA; Klingelhutz AJ
Mutat Res; 2012 Feb; 730(1-2):98-105. PubMed ID: 21605571
[TBL] [Abstract][Full Text] [Related]
7. Telomere rejuvenation during nuclear reprogramming.
Marión RM; Blasco MA
Curr Opin Genet Dev; 2010 Apr; 20(2):190-6. PubMed ID: 20176474
[TBL] [Abstract][Full Text] [Related]
8. Linking Telomere Regulation to Stem Cell Pluripotency.
Liu L
Trends Genet; 2017 Jan; 33(1):16-33. PubMed ID: 27889084
[TBL] [Abstract][Full Text] [Related]
9. Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells.
Batista LF; Pech MF; Zhong FL; Nguyen HN; Xie KT; Zaug AJ; Crary SM; Choi J; Sebastiano V; Cherry A; Giri N; Wernig M; Alter BP; Cech TR; Savage SA; Reijo Pera RA; Artandi SE
Nature; 2011 May; 474(7351):399-402. PubMed ID: 21602826
[TBL] [Abstract][Full Text] [Related]
10. Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients.
Gu BW; Apicella M; Mills J; Fan JM; Reeves DA; French D; Podsakoff GM; Bessler M; Mason PJ
PLoS One; 2015; 10(5):e0127414. PubMed ID: 25992652
[TBL] [Abstract][Full Text] [Related]
11. Suv4-20h abrogation enhances telomere elongation during reprogramming and confers a higher tumorigenic potential to iPS cells.
Marión RM; Schotta G; Ortega S; Blasco MA
PLoS One; 2011; 6(10):e25680. PubMed ID: 22022429
[TBL] [Abstract][Full Text] [Related]
12. Enhanced telomere rejuvenation in pluripotent cells reprogrammed via nuclear transfer relative to induced pluripotent stem cells.
Le R; Kou Z; Jiang Y; Li M; Huang B; Liu W; Li H; Kou X; He W; Rudolph KL; Ju Z; Gao S
Cell Stem Cell; 2014 Jan; 14(1):27-39. PubMed ID: 24268696
[TBL] [Abstract][Full Text] [Related]
13. Alternative Lengthening of Telomeres (ALT) in Tumors and Pluripotent Stem Cells.
Zhao S; Wang F; Liu L
Genes (Basel); 2019 Dec; 10(12):. PubMed ID: 31835618
[TBL] [Abstract][Full Text] [Related]
14. Telomere elongation and naive pluripotent stem cells achieved from telomerase haplo-insufficient cells by somatic cell nuclear transfer.
Sung LY; Chang WF; Zhang Q; Liu CC; Liou JY; Chang CC; Ou-Yang H; Guo R; Fu H; Cheng WTK; Ding ST; Chen CM; Okuka M; Keefe DL; Chen YE; Liu L; Xu J
Cell Rep; 2014 Dec; 9(5):1603-1609. PubMed ID: 25464850
[TBL] [Abstract][Full Text] [Related]
15. Zscan4 promotes genomic stability during reprogramming and dramatically improves the quality of iPS cells as demonstrated by tetraploid complementation.
Jiang J; Lv W; Ye X; Wang L; Zhang M; Yang H; Okuka M; Zhou C; Zhang X; Liu L; Li J
Cell Res; 2013 Jan; 23(1):92-106. PubMed ID: 23147797
[TBL] [Abstract][Full Text] [Related]
16. Comparison of reprogramming ability of mouse ES and iPS cells measured by somatic cell fusion.
Sumer H; Nicholls C; Liu J; Tat PA; Liu JP; Verma PJ
Int J Dev Biol; 2010; 54(11-12):1723-8. PubMed ID: 21404192
[TBL] [Abstract][Full Text] [Related]
17. Telomere dynamics and hematopoietic differentiation of human DKC1-mutant induced pluripotent stem cells.
Donaires FS; Alves-Paiva RM; Gutierrez-Rodrigues F; da Silva FB; Tellechea MF; Moreira LF; Santana BA; Traina F; Dunbar CE; Winkler T; Calado RT
Stem Cell Res; 2019 Oct; 40():101540. PubMed ID: 31479877
[TBL] [Abstract][Full Text] [Related]
18. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells.
Marion RM; Strati K; Li H; Tejera A; Schoeftner S; Ortega S; Serrano M; Blasco MA
Cell Stem Cell; 2009 Feb; 4(2):141-54. PubMed ID: 19200803
[TBL] [Abstract][Full Text] [Related]
19. Telomere dynamics in human pluripotent stem cells.
Ma B; Martínez P; Sánchez-Vázquez R; Blasco MA
Cell Cycle; 2023; 22(23-24):2505-2521. PubMed ID: 38219218
[TBL] [Abstract][Full Text] [Related]
20. A balance between elongation and trimming regulates telomere stability in stem cells.
Rivera T; Haggblom C; Cosconati S; Karlseder J
Nat Struct Mol Biol; 2017 Jan; 24(1):30-39. PubMed ID: 27918544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
